Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis

Volume: 80, Issue: 4, Pages: 543 - 545
Published: Oct 28, 2020
Abstract
Juvenile dermatomyositis (JDM) is a rare systemic autoimmune vasculopathy characterised by weakness in proximal muscles and pathognomonic skin rashes.1 Clinically, some patients are refractory to any available treatments or became steroids dependent.2 The adverse reactions of long-term use of steroids are severe; therefore, more effective and safer medications are urgently needed. JAK inhibitors (JAKi) can reduce interferon (IFN)-induced STAT1...
Paper Details
Title
Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis
Published Date
Oct 28, 2020
Volume
80
Issue
4
Pages
543 - 545
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.